NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 248 filers reported holding NEOGENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,330 | +17.9% | 421 | -37.4% | 0.00% | 0.0% |
| Q4 2022 | $6,219 | +107.3% | 673 | +71.2% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 393 | +214.4% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | -77.8% | 125 | -66.9% | 0.00% | -66.7% |
| Q3 2021 | $18,000 | +80.0% | 378 | +79.1% | 0.00% | +50.0% |
| Q2 2021 | $10,000 | -23.1% | 211 | -23.0% | 0.00% | -66.7% |
| Q1 2021 | $13,000 | +62.5% | 274 | +80.3% | 0.01% | +50.0% |
| Q4 2020 | $8,000 | +33.3% | 152 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $6,000 | +20.0% | 152 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +25.0% | 152 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | +100.0% | 152 | +117.1% | 0.00% | +100.0% |
| Q4 2019 | $2,000 | 0.0% | 70 | -39.1% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | 0.0% | 115 | +64.3% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | +100.0% | 70 | +32.1% | 0.00% | – |
| Q1 2019 | $1,000 | – | 53 | -10.2% | 0.00% | – |
| Q3 2016 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |